25Η (post) Group A

21Η (post) Group B

25Η (pre) Group C

Patients

Hct (%)

Albumin (mg/dl)

Change (%)

At beginning HFD (mg/L)

At the end of HDF (mg/L)

Amount removed (mg)

Hct (%)

Albumin (mg/dl)

Change (%)

At beginning HFD (mg/L)

At the end of HDF (mg/L)

Amount removed (mg)

Hct (%)

Albumin (mg/dl)

Change (%)

At beginning HFD (mg/L)

At the end of HDF (mg/L)

Amount removed (mg)

1

38.1

4.3

69.7

26.99

8.17

245.95

38.3

4.4

71.8

27.65

7.81

260.6

37.9

4.3

66.2

25.25

16.63

259

2

38.5

4.2

71

33.92

9.83

303

38.6

4.1

71.1

33.86

9.97

306.03

40.4

3.9

66.7

29.65

9.86

233.6

3

36.4

4.3

58.4

34.55

14.36

268.64

35.5

4.2

70.7

23.34

7.56

219

44.8

4.6

66

21.3

9.14

159.8

4

38.4

4.1

71

24.21

7.05

227.9

38.6

4.2

72.9

25.6

6.94

237.1

39.3

3.9

63.4

74.58

44.91

214.8

5

42.1

4.4

69.3

22.8

7.0

232

38.0

4.0

69.4

22.2

6.76

200.1

42.4

4.0

64.7

19.33

6.83

157.9

6

37.7

4.1

66.3

19.22

6.48

187

36.3

3.9

66.4

19.33

6.5

200.6

41.6

4.1

59.5

19.52

7.91

118.7

7

39.7

4.6

74.6

32.26

8.21

286.4

36.9

4.8

70

31.09

9.32

277.4

33.0

4.2

62

33.17

16.62

271.6

8

34.7

3.8

49.9

14.25

7.14

198.8

33.3

4.1

60.6

21.41

8.44

216.08

39.3

4.0

62.1

20.36

7.71

177

9

39.7

3.4

68.8

19.63

6.13

159.1

39.3

4.0

70.5

20.88

6.16

161

38.1

3.7

71.6

19.81

5.62

133.7

10

34

3.7

71.8

28.91

8.34

290.7

35.2

3.7

70.6

28.75

8.46

121.4

36.4

3.8

67.6

27.72

8.99

140.7

11

37.6

4.0

68.8

27.57

8.6

135.8

36.7

3.9

67

25.02

8.26

173.74

36.7

4.0

67

26.13

8.62

167.58

12

37.5

4.3

76.5

25.96

6.1

226.3

36.5

4.0

72.1

24.23

6.78

211.7

38.0

4.0

65.7

25.51

8.76

176.4

7M, 5F

37.9

±

2

4.1

±

0.32

68

±

6.9

25.9

±

5.9

8.1

±

2.2

213

±

76.6

36.9

±

1.66

4.1

±

0.27

69.4

±

3.2

25.3

±

4.2

7.8

±

1.1

215.4

±

48.8

39

±

2.96

4.04

±

0.23

65.2

±

3.0

28.5

±

14.5

12.6

±

10.3

184.2

±

47.5